Teladoc Health, Inc.
TDOC
$6.47
-$0.07-1.07%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -177.40M | -171.15M | -200.32M | -223.59M | -207.36M |
| Total Depreciation and Amortization | 221.77M | 216.65M | 208.82M | 204.88M | 210.96M |
| Total Amortization of Deferred Charges | 156.19M | 163.80M | 167.62M | 164.00M | 157.59M |
| Total Other Non-Cash Items | 68.03M | 72.72M | 117.17M | 139.50M | 144.09M |
| Change in Net Operating Assets | -7.42M | 5.93M | 1.08M | 7.72M | -1.85M |
| Cash from Operations | 261.18M | 287.95M | 294.36M | 292.52M | 303.43M |
| Capital Expenditure | -7.49M | -7.83M | -8.89M | -12.41M | -11.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -16.60M | -17.30M | -81.90M | -81.90M | -65.30M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.06M | -154.13M | -175.21M | -167.02M | -166.73M |
| Cash from Investing | -161.15M | -179.26M | -266.00M | -261.33M | -243.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -550.63M | -550.63M | -550.63M | -550.63M |
| Issuance of Common Stock | 2.89M | 2.72M | 3.09M | 3.86M | 4.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.96M | -6.96M | -4.11M | -3.93M | -83.00K |
| Cash from Financing | -4.06M | -554.87M | -551.65M | -550.70M | -546.41M |
| Foreign Exchange rate Adjustments | -1.24M | 3.58M | 6.06M | 1.89M | 3.97M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.73M | -442.59M | -517.24M | -517.62M | -482.76M |